home / stock / airs / airs news


AIRS News and Press, AirSculpt Technologies Inc. From 03/11/22

Stock Information

Company Name: AirSculpt Technologies Inc.
Stock Symbol: AIRS
Market: NASDAQ
Website: elitebodysculpture.com

Menu

AIRS AIRS Quote AIRS Short AIRS News AIRS Articles AIRS Message Board
Get AIRS Alerts

News, Short Squeeze, Breakout and More Instantly...

AIRS - AirSculpt Technologies reports Q4 results

AirSculpt Technologies press release (NASDAQ:AIRS): Q4 Revenue of $37.56M (+64.4% Y/Y) beats by $3.04M. Cases increased 43.8% from prior year period to 2,885 cases. Same-center revenue per case increased 13.1% from the prior year period. Same-center cases increased 19.6% from the prior year p...

AIRS - AirSculpt Technologies, Inc. Announces Fourth Quarter and Full Year 2021 Results

MIAMI BEACH, Fla., March 11, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and full year ended December ...

AIRS - AirSculpt Technologies Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call

MIAMI BEACH, Fla., Feb. 18, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) today announced that the company will release its fourth quarter and full year results before market open on Friday, March 11, 2022, to be followed by a conference ca...

AIRS - AirSculpt Technologies, Inc. (AIRS) CEO Aaron Rollins on Q3 2021 Results - Earnings Call Transcript

AirSculpt Technologies, Inc. (AIRS) Q3 2021 Earnings Conference Call December 03, 2021, 08:30 AM ET Company Participants Dennis Dean - CFO Aaron Rollins - CEO Ronald P. Zelhof - COO Conference Call Participants Simeon Gutman - Morgan Stanley Whit Mayo - SVB Leerink Parker Snure - Raymond Jame...

AIRS - Celyad Oncology, Longeveron leads healthcare gainers; Esperion Therapeutics, Biofrontera among major losers

Gainers: Celyad Oncology CYAD +41%, Longeveron LGVN +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies AIRS +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%. Losers: Esperion Therapeutics ESPR -40%, Biofrontera (NASDAQ:...

AIRS - AirSculpt Technologies gains after setting guidance ahead of consensus

The shares of AirSculpt Technologies (AIRS +7.2%) have recorded a double-digit gain in percentage terms after reporting better-than-anticipated revenue for Q3 2021 and setting its 2021 outlook slightly ahead of expectations. The healthcare service provider focused on fat removal procedures sa...

AIRS - AirSculpt Technologies beats on revenue

AirSculpt Technologies (NASDAQ:AIRS): Q3 Net Income of $8.1M Revenue of $34.65M (+94.3% Y/Y) beats by $0.46M. Shares -6.02% AH. Press Release The Company projects full year revenue to be approximately $130 million vs consensus of $129.82M and full year Adjusted EBITDA to be approximately...

AIRS - AirSculpt Technologies, Inc. Announces Third Quarter 2021 Results

MIAMI BEACH, Fla., Dec. 03, 2021 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2021. ...

AIRS - Biotech IPOs like iSpecimen soar on COVID fears, but in-person servicers like AirSculpt sink

Friday’s COVID-related market selloff had a mixed impact on shares of recent IPOs – with lockdown-sensitive names like fat-removal firm AirSculpt Technologies (NASDAQ:AIRS) sinking, but biotechs like iSpecimen (NASDAQ:ISPC) and in-home fitness firms like Beachbody (NYSE:BODY) ra...

AIRS - Catalyst watch for next week: Zoom Video and Best Buy earnings, Merck R&D Day and UiPath event

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Previous 10 Next 10